Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/1346-8138.15903 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Concurrent Zoster Sine Herpete and Hepatosplenic Fungal Infection in a Cancer Patient: A Case Report.
Cureus
October 2024
Infectious Diseases and Tropical Medicine, Moffitt Cancer Center, Tampa, USA.
In patients undergoing treatment for hematological cancers, like hairy cell leukemia (HCL), appropriate management of infections is of utmost importance. This paper describes the successful treatment of an HCL patient who had both visceral zoster sine herpete (ZSH) and hepatosplenic fungal infection, possibly caused by . To our knowledge, this is the first such case to appear in the literature, as these are rare conditions associated with states of immunosuppression, similar to those observed in hematological malignancy.
View Article and Find Full Text PDFAn Intriguing Case of Hepatosplenic Lesions and Pneumonia During Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease.
Gastroenterology
November 2024
Division of Gastroenterology, Department of Medicine, Inflammatory Bowel Diseases Center, University Hospital of the Federal University of Juiz de Fora, University of Juiz de Fora School of Medicine, Minas Gerais, Brazil. Electronic address:
Gallbladder schistosomiasis.
Autops Case Rep
October 2024
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Departamento de Gastroenterologia e Nutrologia, Divisão de Cirurgia do Aparelho Digestivo, São Paulo, SP, Brasil.
Schistosomiasis is an infectious disease caused by parasitic flatworms of the genus Schistosoma. The species is associated with hepatosplenic disease. Schistosomiasis involving the gallbladder alone is highly unusual, with a few cases reported.
View Article and Find Full Text PDFLong-Term Survival in Canine Hepatosplenic T-Cell Lymphoma Treated with Toceranib Phosphate Following Splenectomy: A Case of Atypical Lymphoma.
Vet Sci
October 2024
Laboratory of Clinical Diagnosis, Azabu University, Sagamihara 252-5201, Kanagawa, Japan.
Article Synopsis
- Toceranib phosphate is an approved treatment for canine mast cell tumors, but its long-term effectiveness for canine hepatosplenic T-cell lymphoma (HSTCL) has not been previously reported.
- A 10-year-old dog presented with weight loss and other symptoms, leading to the discovery of HSTCL through various tests and surgeries, including a splenectomy and liver biopsy.
- After starting toceranib treatment, the dog's liver enzyme levels decreased and it remained in good condition, demonstrating that toceranib may be a viable treatment option for HSTCL in dogs, with the dog surviving for 460 days post-treatment.
The peculiar clinical presentation and diagnostic results of a case of widely metastatic cholangiocellular carcinoma in a Siberian Husky dog.
Top Companion Anim Med
December 2024
Department of Comparative Pathobiology, Cummings School of Veterinary Medicine, Tufts University, 200 Westboro Road, North Grafton, MA 01536, USA. Electronic address:
Article Synopsis
- A six-year-old spayed female Siberian Husky presented with cervical pain, ataxia, respiratory changes, and significant weight loss, leading to a battery of diagnostic tests.
- Findings indicated serious health issues, including spinal myelopathy and signs suggestive of metastatic carcinoma, prompting humane euthanasia and further investigation through necropsy.
- The necropsy revealed multiple tumors consistent with cholangiocellular carcinoma, highlighting challenges in prior diagnostics and an unusual presentation with cervical pain likely linked to spinal metastasis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!